Stockreport

RedHill Biopharma Announces Full-Year 2023 Results and Operational Highlights [Yahoo! Finance]

Redhill Biopharma Ltd. - American Depositary Shares  (RDHL) 
US:NASDAQ Investor Relations: ir.redhillbio.com/investor-relations
PDF Focused externally funded R&D: Opaganib for nuclear and chemical medical countermeasure (NIH funding): Selected for evaluation by two U.S. government countermeasures [Read more]